Infection by Candida species is the most common cause of infectious esophagitis in adults. Esophageal candidiasis (EC) occurs most commonly in immunocompromised hosts, such as those with human immunodeficiency virus infection. However, EC may also occur in immunocompetent individuals with or without apparent predisposing risk factors and symptoms. We report a case of EC incidentally discovered in an immunocompetent middle age male who underwent esophagogastro-duodenoscopy for dyspeptic symptoms. The only potential risk factor was long-term use of alcohol. Treatment with fluconazole led to complete resolution of EC.
INTRODUCTION
Esophageal candidiasis (EC) is one of the most common opportunistic infections in patients with impaired cellular immunity, such as human immunodeficiency virus (HIV) [1] infection. However, EC has also been reported to occur in immunocompetent individuals with or without apparent [2] [3] [4] [5] predisposing risk factors and symptoms.
Various risk factors implicated to cause EC in immunocompetent individuals include broad-spectrum antibiotics, proton-pump inhibitors (PPI), H2-receptor antagonists, esophageal diseases such as noninfectious esophagitis or achalasia, and use of [2] [3] [4] [5] corticosteroid/cytotoxic drugs. Other conditions associated with an increased incidence of EC include alcoholism, [2] [3] [4] [5] malnutrition, and advanced age.
Most of the patients detected to have EC on esophago-gastro-duodenoscopy (EGD) are asymptomatic, and typical esophageal symptoms [2] are uncommon. We report a case of EC incidentally discovered in an immunocompetent middle age male who underwent EGD for dyspeptic symptoms.
CASE REPORT
A 49 year old male patient presented to gastroenterology OPD with complaints of epigastric discomfort since one month. There was no history of nausea, vomiting, hematemesis, melena, diarrhea, constipation, weight loss, jaundice or fever. He used to consume about 100 gram of alcohol daily since last 20 years. There was no history of smoking, or drug abuse. He was taking PPI (Tab esomeprazole 40 mg, once daily) since 3 weeks. He denied any use of analgesics or antibiotics in the last one year Physical examination revealed a well nourished, moderately built person. He had a blood pressure of 124/80 mm Hg and heart rate of 74 beats per minute. His oral cavity was normal with no signs of infection or thrush. He had mild epigastric discomfort with no rebound tenderness or guarding. Rest of physical examination was unremarkable. Laboratory investigations revealed 62 IU/ml alanine transaminase and 85 IU/ml aspartate transaminase. Other investigations including serum bilirubin, albumin, complete blood counts, renal function tests, thyroid function test and glycosylated hemoglobin were normal. Ultrasonography of abdomen and pelvis revealed hepatomegaly with fatty liver. Further, EGD was performed, which revealed multiple whitish plaques throughout esophagus with underlying ulceration (Fig.1 ). Stomach and duodenum were normal. Brushings from the lesions revealed spores and pseudohyphae of Candida infiltrating the mature squamous cells at places (Fig. 2) . He was further investigated to rule out immunocompromised state. HBsAg, anti-HCV, .
anti-HIV, syphilis screen, anti-nuclear antibodies and Tlymphocyte counts were normal. He was treated with Tab fluconazole 200 mg once daily for two weeks. Repeat endoscopy performed three weeks later showed complete resolution of esophageal candidiasis.
DISCUSSION
Esophageal candidiasis has been commonly reported to occur in immunocompromised patients, especially those [1] infected with HIV infection. However, the regular use of screening EGD has led to more frequent diagnosis of EC in [6] healthy individuals. The prevalence of EC among patients undergoing EGD has varied from 0.32% (281/88125) by Choi [2] [7]
et al and 1.17% (41/3501) by Naito et al to 8.7% by Kakati [8] et al from India.
The development of EC is a two-step process consisting of colonization of the esophagus and subsequent invasion of [9] the epithelial layer. It is already well accepted that Candida are known to colonize the esophagus of 20% of healthy adults. Once colonization has been established, impaired cellular immunity, such as due to HIV infection, permits invasion of [9] the epithelial layer.
The usual causative agent is Candida albicans, but other Candida species have also been isolated from cases of esophagitis. In a recent report from India, C. albicans was recovered from the majority of patients (52.1%), followed by C. tropicalis (24%), C. parapsilosis (13.4%), C. glabrata [8] (6.9%) and C. krusei (3.6%). Alarmingly, among the C. albicans isolates 8.6% were resistant to fluconazole.
In immunocompetent persons, various risk factors for EC have been identified. PPI, H2-receptor antagonists, and prior vagotomy may increase the risk of EC by elevation of gastric pH and altering the colonization of the esophagus by oral [2, 3] cavity bacteria and yeast. Broad-spectrum antibiotics may eliminate certain bacteria that inhibit fungal growth, thereby allowing overgrowth and colonization of the Candida [2] species. Corticosteroids and various cytotoxic drugs predispose to candidiasis by suppressing both lymphocyte and [2] granulocyte function. EC has also been seen in cases of functional or mechanical obstruction of the esophagus, where [2, 3] stasis leads to excessive growth of the fungus. Previously, diabetes was considered as risk factor for EC because of [2] impaired immunity and stasis of esophageal contents. However, most of the cases of diabetes-related EC reported have been associated with chronic poor glycemic control (hyperglycemia more than 2 years) and combined with secondary factors, such as those causing an immuno [2] compromised state. Our case had two potential risk factors for EC i.e long standing alcohol intake and use of acid suppressing medications.
As in our case, esophageal symptoms are more frequently [2] absent in individuals with EC. In studies by Choi et al and [7] Naito et al, about two-thirds of the patients had no symptoms. In those who were symptomatic, variable gastrointestinal symptoms included epigastric discomfort, dyspepsia, nausea etc. Classical symptoms of infectious
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Goyal et al esophagitis, such as dysphagia, odynophagia and chest [2, 7] discomfort have been reported in only about 10% patients. It is questionable whether the gastrointestinal symptoms are associated with EC and whether this has a clinical significance. On follow-up, about three-fourth of the cases of [2] EC have been shown to disappear spontaneously.
The endoscopic appearance of Candida esophagitis ranges from a few superficial white plaques on the mucosal surface to a dense, thick pseudomembrane composed of desquamated squamous epithelial cells, fungus, and fibrin. Histologically, in the presence of invasive candidal esophagitis, Candida species are seen along with squamous cells and invading hyphae on smears.
Although most cases of EC may remain silent and invasion of esophageal wall is usually limited to the superficial epithelium, extensive tissue necrosis and [10] ulceration resulting in esophageal perforation is possible. There have been a few reported cases of esophageal perforation associated with Candida infection, and most of these predominantly occurred in immunocompromised hosts, such as transplanted or leukemia patients. It is possible that neutropenia, irradiation and chemotherapy such as methotrexate might have led to mucosal disruption, thereby [10] facilitating deeper invasion of the esophagus by Candida. In immunocompetent hosts, chronic alcohol consumption and long-standing gastroesophageal reflux may increase the risk of transmural invasive Candida infection and esophageal [10] perforation.
Our case highlights the fact that EC can occur in immunocompetent persons without esophageal symptoms. Confirmation by histopathology and adequate treatment is warranted to prevent complications, especially in persons with underlying risk factors.
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